General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Why Rivian Stock Investors Need Nerves of Steel Amid Mixed Outlook | news.google.com • |
The US Stock Market's Outlook: Further Gains in 2024 Mainly Dependent on Rate Cuts? | news.google.com • |
Salesforce Shares Plunge by Most Since 2008 After Weak Outlook | news.google.com • |
Nutanix Stock: Earnings Beat, While Revenue Outlook Misses. Shares Tumble | news.google.com • |
Salesforce Stock Plunges on Q1 Revenue Miss, Soft Outlook | news.google.com • |
Kohl’s Q1 Earnings: Revenue And Profit Miss, Outlook Cut, Stock Tumbles Why Department Store Chain Kohl's | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-15 | 2024-03 | -0.88 | -1.55 | -0.67 | -76.14% |
2024-02-14 | 2023-12 | -1 | -0.8 | 0.2 | 20.00% |
2023-12-22 | 2023-09 | -1 | -1 | N/A | N/A |
2023-08-14 | 2023-06 | -0.8 | -1.6 | -0.8 | -100.00% |
2023-05-15 | 2023-03 | -1.2 | -0.6 | 0.6 | 50.00% |
2023-02-14 | 2022-12 | -0.8 | -1.6 | -0.8 | -100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Chardan Capital | Downgrade | Buy | Neutral |
2023-08-30 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-08-29 | Brookline Capital | Downgrade | Buy | Hold |
2023-08-29 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
2023-08-29 | BTIG | Downgrade | Buy | Neutral |
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-04-19 | DAGNON TERRY | Chief Operating Officer | 653.06K | Sale |
2024-03-06 | EVANSON JEFF | Officer | 808.46K | Purchase |
2024-03-27 | HADDADIN YEZAN MUNTHER | Director | 5.05K | Purchase |
2022-10-04 | HILZINGER KURT J | Director | 473.12K | Purchase |
2021-04-19 | KENYON LAWRENCE A. | Chief Executive Officer | 18.93K | Purchase |
2022-10-06 | SUKHTIAN FAISAL GHIATH | Director | 68.00K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 9.22M | 16.04M | 3.54% |
2023-06-29 | Vanguard Group Inc | 6.15M | 10.70M | 2.36% |
2023-06-29 | State Street Corporation | 2.75M | 4.79M | 1.06% |
2023-06-29 | Geode Capital Management, LLC | 2.72M | 4.73M | 1.05% |
2023-06-29 | Northern Trust Corporation | 1.26M | 2.18M | 0.48% |
2023-06-29 | Nuveen Asset Management, LLC | 598.96K | 1.04M | 0.23% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.61M | 6.28M | 1.39% |
2023-08-30 | iShares Russell 2000 ETF | 3.58M | 815.24K | 1.37% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.45M | 2.52M | 0.56% |
2023-07-30 | Fidelity Small Cap Index Fund | 1.38M | 2.38M | 0.53% |
2023-08-30 | iShares Russell 2000 Growth ETF | 1.27M | 289.29K | 0.49% |
2023-05-30 | Fidelity Extended Market Index Fund | 519.75K | 779.62K | 0.20% |
Split | Date |
---|---|
1 : 20 | 2024-03-14 |
1 : 8 | 2019-03-18 |
$OTLK 1++++ after hours. News incoming
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi
-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.
“The term float refers to the regular shares a company has issued to the public that are available for investors to trade. This figure is derived by taking a company's outstanding shares and subtracting any restricted stock, which is stock that is under some sort of sales restriction. “
We are almost 100% of stock float today. That is almost 100% long investors. Where, oh where will the shorts find stocks to cover? Longs stay strong and make them pay.
Shorts are driving price down with artificial supply. The more shorts in the game makes it harder to get out. Payback is a bitch and unlike long there is no limit to their loses. Their loss is our gain. Sit tight and wait til payday
Is anyone else wondering where the shares are coming from. There are only 128 million share float for trading and 94.5 million shares traded today. Between the institutional that have been quietly buying and independent long holders…. There shouldn’t be many physical shares able to be traded. Shouldn’t the low supply be driving the price higher? How are the shorts going to cover? This is getting very interesting 🧐
Mister wizard only shows up when he is losing money. He is just an angry short trader. He gets more vicious, the more he loses.
Pinch the shorts and stop London
I stopped lending shares today. Time to pick the shorts
Waldo, here is some friendly advice. Don’t stand to close to the exit when short start stampeding to the door. They are getting nervous and anything except them off running
Frank, how come we only hear from you when you are losing money. You sure do get cranky calling everyone clowns…. Shouldn’t you be calling your broker to cover yourA$$.
Frank, here are the real fax EMA often approves medication’s that are not approved by the FDA. In fact, this molecule has more indications currently in Europe than in the United States. Get your facts straight.
Waldo, how much have you lost today? It’s time for shorts to go. You have had your fun.
Frank, do you have any evidence to back the B.S. that you post. No one here cares about your unfounded opinions.
Frank Chance the only sucker/clown at the table. We all know every penny OTLK goes up is a penny you lose. Do you have any education in finance or pharmaceuticals????
If the law suit is successful the lawyers will get millions. The investors will so little they will wish they didn’t waist their time. It is way to early to be thinking law suit. The current lawyer are ambulance chasers…. They may not be the best choice for representation…. When the time comes. Do keep in mind if they don’t get approved that you will have no case. If it doesn’t get approved there will be nothing there to sue for. This was always a big bet with the possibility of huge up side. You don’t lose until you sell. If you can’t ride it out then you shouldn’t have been here to start with. For full disclosure, I am long and believe it will be approved …. In time.
If you want to know why your outlook stock isn’t going up, call your broker and ask him to stop letting your shares. You are cutting your own throat by lending against yourself with a gluttony of shares on the market that don’t actually exist. It ONLY takes a phone call!
Lack of substantial evidence can be used in two forms by the FDA. First efficacy and safety of a new molecule second proving that the molecule can be produced in a safe and efficient manner meeting, safety, standards of efficacy, and quality. When the FDA inspected the facility, they did not do three checks of the product only one they also failed to clean the equipment properly. Thus, outlook was not able to show substantial evidence of its ability to produce the product. The FDA has use this term for this type of a problem for a very long time do your homework it’s easy to look up with multiples of examples.
Frank, who is the clown now? If what you said is true only a fool bets a $1.48 against a .12 cent gain. Why are you still here?
With the possibility of law suites, no one in their right mind is going to say anything but hard facts. If you are looking for predictions or hints you won’t find them at financial meetings. You can thank the lawyers for ambulance chasing early.